(VIANEWS) – PANORO ENERGY (PEN.OL), REACH SUBSEA (REACH.OL), MONTEA (MONT.BR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. PANORO ENERGY (PEN.OL)
98.5% sales growth and 11.06% return on equity
Panoro Energy ASA, an independent exploration and production company, engages in the exploration, development, and production of oil and gas in Africa. The company holds assets in the Equatorial Guinea, Gabon, Tunisia, South Africa, and Nigeria. The company was incorporated in 2009 and is headquartered in London, the United Kingdom.
Earnings Per Share
As for profitability, PANORO ENERGY has a trailing twelve months EPS of kr0.32.
PE Ratio
PANORO ENERGY has a trailing twelve months price to earnings ratio of 88.38. Meaning, the purchaser of the share is investing kr88.38 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.06%.
More news about PANORO ENERGY.
2. REACH SUBSEA (REACH.OL)
71.2% sales growth and 16.67% return on equity
Reach Subsea ASA provides subsea services in Norway and internationally. It operates in two segments, Oil & Gas and Renewable/Other. The company offers inspection, maintenance, and repair services, such as structural inspections, WROV operation, SCM changeout, scale squeeze operations, water injection, ready for operation, subsea equipment maintenance, repair, commissioning, and boulder clearance; and construction support services, including seabed intervention, boulder clearance, touchdown monitoring, and pre-lay and post- lay survey, as well as vessel, remotely operated vehicles, personnel, survey, and on demand engineering. It also provides asset integrity/pipeline inspection, and engineering and project management services; reach remote services comprising survey, inspection, and IMR and seabed intervention; seabed survey services consisting of site surveys and geohazard investigation, pipeline inspection, seabed mapping, UXO, general, and route surveys; offshore cable; marine construction; and rig and mooring services. In addition, the company offers geophysical monitoring services, which include 4D gravity, seafloor subsidence monitoring, depth watch for seismic nodes, injection integrity monitoring, well drilling, and real time seismic monitoring services; and environmental monitoring services that comprise earthquake monitoring and prediction, C02 storage, and geothermal energy exploitation. It serves oil and gas, renewables, and utilities sectors. The company was formerly known as Transit Invest ASA and changed its name to Reach Subsea ASA in December 2012. Reach Subsea ASA was incorporated in 1909 and is headquartered in Haugesund, Norway.
Earnings Per Share
As for profitability, REACH SUBSEA has a trailing twelve months EPS of kr0.34.
PE Ratio
REACH SUBSEA has a trailing twelve months price to earnings ratio of 13.15. Meaning, the purchaser of the share is investing kr13.15 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.67%.
More news about REACH SUBSEA.
3. MONTEA (MONT.BR)
25.8% sales growth and 17.64% return on equity
Montea is a developing investor in logistics real estate in Belgium, France, Germany and the Netherlands. Our team of passionate specialists creates the ideal real estate solution together with the customer.
Earnings Per Share
As for profitability, MONTEA has a trailing twelve months EPS of €12.36.
PE Ratio
MONTEA has a trailing twelve months price to earnings ratio of 6.27. Meaning, the purchaser of the share is investing €6.27 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.64%.
Volume
Today’s last reported volume for MONTEA is 2163 which is 88.83% below its average volume of 19373.
Revenue Growth
Year-on-year quarterly revenue growth grew by 26.3%, now sitting on 111.01M for the twelve trailing months.
Yearly Top and Bottom Value
MONTEA’s stock is valued at €77.50 at 22:20 EST, way under its 52-week high of €118.20 and way higher than its 52-week low of €62.20.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MONTEA’s EBITDA is 11.78.
More news about MONTEA.
4. SPAREBANK 1 SMN (MING.OL)
17.6% sales growth and 11.54% return on equity
SpareBank 1 SMN, together with its subsidiaries, provides various banking, accounting, and real estate products and services to private individuals and companies in Norway and internationally. The company offers mortgage, car, boat, other vehicles, and consumer loans; refinancing; and current, savings, billing, business, group, tax deduction, currency, and deposit accounts. It also provides BSU house savings for young people; fixed interest deposits; stocks and investments; cash services; and payments. In addition, the company offers vehicle, housing and travel, person, animal, and valuables insurance services; property buying and selling advisory services; and mobile and online banking, and various cards. Further, it offers loans and financing, including bank guarantees, business and construction loans, operating credit for agriculture, factoring, guarantees, leasing, and overdrafts; various pension products; and business and personal insurance products. Additionally, the company provides document collection, letter of credit, future business, and currency option services; and services, including accounting and payroll, HR, taxes and duties, and transfer of ownership, as well as IT solutions. It offers real estate agency, advisory, and external and equity financing services. SpareBank 1 SMN was founded in 1823 and is headquartered in Trondheim, Norway.
Earnings Per Share
As for profitability, SPAREBANK 1 SMN has a trailing twelve months EPS of kr11.43.
PE Ratio
SPAREBANK 1 SMN has a trailing twelve months price to earnings ratio of 11.67. Meaning, the purchaser of the share is investing kr11.67 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.54%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 33.3%, now sitting on 5.95B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 10.6% and 24.7%, respectively.
Moving Average
SPAREBANK 1 SMN’s worth is above its 50-day moving average of kr129.33 and higher than its 200-day moving average of kr122.18.
More news about SPAREBANK 1 SMN.
5. KITRON (KIT.OL)
15% sales growth and 21% return on equity
Kitron ASA operates as an electronics manufacturing services company in Norway, Sweden, rest of Europe, the United States, and internationally. It manufactures electronics that are embedded in the customers' products; and box-built electronic products. The company's services include development services, such as product development, product management, and re-engineering services; and industrialization services, including prototype manufacturing, evaluation of new products, component engineering and database, test development, design and build of high level assembly lines, and environmental durability testing. Its services also comprise sourcing and procurement services; manufacturing, assembling, and testing of electronic products for the professional market; redesign, repair, and maintenance; and logistics and distribution services. The company was incorporated in 1996 and is headquartered in Billingstad, Norway.
Earnings Per Share
As for profitability, KITRON has a trailing twelve months EPS of kr1.39.
PE Ratio
KITRON has a trailing twelve months price to earnings ratio of 25.79. Meaning, the purchaser of the share is investing kr25.79 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21%.
More news about KITRON.
6. NAVAMEDIC (NAVA.OL)
9.6% sales growth and 16.31% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, women's health, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr0.45.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 82. Meaning, the purchaser of the share is investing kr82 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.31%.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr36.90 at 22:20 EST, way under its 52-week high of kr43.60 and way above its 52-week low of kr25.00.
More news about NAVAMEDIC.